Results 61 to 70 of about 306,427 (235)
A phenomap of TTR amyloidosis to aid diagnostic screening
ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos +4 more
wiley +1 more source
Heart disease in infants of diabetic mothers [PDF]
, 2000 Congenital anomalies occur more commonly in infants born to diabetic mothers, and cardiac defects predominate. Although respiratory problems are also frequently found in those infants, they need to be differentiated from cardiovascular problems that ...
Narchi, Hassib, Kulaylat, N.
core
4 Cases of Midventricular Obstructive Hypertrophic Obstructive Cardiomyopathy
, 1996 In hypertrophic cardiomyopathy, the distribution and extent of left ventricular hypertrophy is known to be variable. Among the subtypes of hypertrophic cardiomyopathy, midventricular obstruction is a rare variant of obstructive hypertrophic ...
이문형 +4 more
core +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Longer‐term morbidity post septal myectomy (SM) in obstructive hypertrophic cardiomyopathy has not been well characterized at a national level.
Ahmed Altibi +6 more
doaj +1 more source
, 2022 Lawin D, Stellbrink C, Marx K, Danielsmeier NB, Poudel MR, Lawrenz T. Gender-disparities in patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy. European Heart Journal . 2022;43(Suppl.
Lawrenz, Thorsten +5 more
core +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective Heavy menstrual bleeding is one of the most common gynecologic disorders among women of reproductive age and has a significant impact on their physical, psychological, and social well‐being. Although international guidelines recommend medical therapy as the first‐line treatment, it may prove ineffective, poorly tolerated, or ...
Jonas Rudaitis +3 more
wiley +1 more source
Mavacamten for hypertrophic obstructive cardiomyopathy [PDF]
The Lancet, 2021 Eduard, Quintana +2 more
openaire +2 more sources
Genetic Biomarkers in the Risk Assessment of Sudden Cardiac Events: A Personalized Approach
iNew Medicine, EarlyView.Genetic insights into the risk assessment of sudden cardiac events. ABSTRACT Sudden cardiac events are the leading cause of death worldwide. Conventional risk stratification methods, which largely depend on clinical history, imaging, and electrocardiography, are usually inadequate for identifying high‐risk individuals, especially those without visible ...
Shrikant Verma +5 more
wiley +1 more source
Case Reports in Medicine, 2012 Hypertrophic cardiomyopathy (HCM) with midventricular obstruction (MVO) is a rare condition occurring in 1% of HCM patients. It is characterized by asymmetric left ventricular hypertrophy with MVO and elevated intraventricular pressure gradients ...
Leila Abid +4 more
doaj +1 more source
Imaging in Obstructive Hypertrophic Cardiomyopathy
, 2022 This video discusses the role of multimodality imaging (echocardiography and cardiac magnetic resonance or CMR) in identifying various phenotypes of hypertrophic cardiomyopathy (HCM) patients who demonstrate dynamic LV outflow tract obstruction. It
Milind Desai (12316307)
core +1 more source